Literature DB >> 9778034

Identification of human autoantigen La/SS-B as BC1/BC200 RNA-binding protein.

J Kremerskothen1, M Nettermann, A op de Bekke, M Bachmann, J Brosius.   

Abstract

Rodent BC1 RNA and primate BC200 RNA are small cytoplasmic non-messenger RNAs that are phylogenetically unrelated. Nevertheless, the two RNAs exhibit a large degree of parallelism. In addition to some sequence similarities in their 3' domains, they are prevalently expressed in a similar subset of neurons and belong to a small group of transcripts with a somatodendritic location. Both RNAs are complexed with proteins as ribonucleoprotein particles (RNPs). Their similarities may even extend to analogous functional roles, for example, in the regulation of decentralized dendritic translation. To shed further light on the physiological role(s) of the BC1/BC200 RNPs, we began to analyze protein components that specifically bind to these RNAs. Ultraviolet-crosslinking experiments and affinity purification techniques revealed that the human autoantigen La/SS-B is associated with BC1/BC200 RNA in vitro and in vivo. As with other RNA polymerase III transcripts, La protein binds with high affinity to the 3' end of BC200 RNA. Our results suggest that an additional function of La may be control of dendritic translation by providing a link between the 5' Alu domain of BC200 RNP and the ribosome via the La protein dimer. The fact that La binds both BC1 and BC200 RNAs further supports the notion that the RNAs are functional analogs despite the fact that they arose from two separate retroposition events in two different mammalian lineages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778034     DOI: 10.1089/dna.1998.17.751

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  6 in total

1.  Implication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells.

Authors:  Gunhild Sommer; Carlos Rossa; Angela C Chi; Brad W Neville; Tilman Heise
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

2.  Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.

Authors:  Claudia Arndt; Ralf Bergmann; Franziska Striese; Keresztély Merkel; Domokos Máthé; Liliana R Loureiro; Nicola Mitwasi; Alexandra Kegler; Frederick Fasslrinner; Karla Elizabeth González Soto; Christin Neuber; Nicole Berndt; Noemi Kovács; David Szöllősi; Nikolett Hegedűs; Gyula Tóth; Jan-Philipp Emmermann; Kuzhuvelil B Harikumar; Tibor Kovacs; Michael Bachmann; Anja Feldmann
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

3.  The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.

Authors:  Alexander H Staudacher; Fares Al-Ejeh; Cara K Fraser; Jocelyn M Darby; David M Roder; Andrew Ruszkiewicz; Jim Manavis; Michael P Brown
Journal:  EJNMMI Res       Date:  2014-01-04       Impact factor: 3.138

Review 4.  BC200 (BCYRN1) - The shortest, long, non-coding RNA associated with cancer.

Authors:  J Samson; S Cronin; K Dean
Journal:  Noncoding RNA Res       Date:  2018-05-22

5.  RNA-Binding Protein La Mediates TGFβ-Induced Epithelial to Mesenchymal Transition and Cancer Stem Cell Properties.

Authors:  Tilman Heise; Gunhild Sommer
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

6.  Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.

Authors:  Vasilios Liapis; William Tieu; Nicole L Wittwer; Tessa Gargett; Andreas Evdokiou; Prab Takhar; Stacey E Rudd; Paul S Donnelly; Michael P Brown; Alexander H Staudacher
Journal:  Mol Imaging Biol       Date:  2021-07-06       Impact factor: 3.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.